Pain Facilitation Brain Regions Activated by Nalbuphine Are Revealed by Pharmacological fMRI

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Gear, Robert ^a   Becerra, Lino ^b,c,d   Upadhyay, Jaymin ^b,c   Bishop, James ^b,c   Wallin, Diana ^b,c   Pendse, Gautam ^b,c   Levine, Jon ^a   Borsook, David ^b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCLEAN HOSPITAL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; NALBUPHINE; NALOXONE; SODIUM CHLORIDE;

ADULT; ANALGESIA; ARTICLE; BOLD SIGNAL; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; INSULA; MALE; NORMAL HUMAN; OCCIPITAL CORTEX; PAIN; PONS; POSTERIOR INSULA; PULVINAR; PUTAMEN; RANDOMIZATION; TEMPORAL CORTEX;

BRAIN; BRAIN MAPPING; HUMANS; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; NALBUPHINE; NALOXONE; NERVE NET; ORGAN SPECIFICITY; OXYGEN; PAIN; PSYCHOPHYSICS; YOUNG ADULT;

EID: 84872191986     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050169     Document Type: Article

References (42)

1. Gordon NC, Gear RW, Heller PH, Paul S, Miaskowski C, et al. (1995) Enhancement of morphine analgesia by the GABAB agonist baclofen. Neuroscience 69: 345-349.
2. Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, et al. (1996) Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med 2: 1248-1250.
3. Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, et al. (1999) The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain. Pain 83: 339-345.
4. Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, et al. (2000) Action of naloxone on gender-dependent analgesic and anti-analgesic effects of nalbuphine in humans. J Pain 1: 122-127.
5. Schmidt WK, Tam SW, Shotzberger GS, Smith DH Jr, Clark R, et al. (1985) Nalbuphine. Drug Alcohol Depend 14: 339-362.
6. Leslie RA, James MF, (2000) Pharmacological magnetic resonance imaging: a new application for functional MRI. Trends Pharmacol Sci 21: 314-318.
7. Honey G, Bullmore E, (2004) Human pharmacological MRI. Trends Pharmacol Sci 25: 366-374.
8. Becerra L, Harter K, Gonzalez RG, Borsook D, (2006) Functional magnetic resonance imaging measures of the effects of morphine on central nervous system circuitry in opioid-naive healthy volunteers. Anesth Analg 103: 208-216.
9. Borras MC, Becerra L, Ploghaus A, Gostic JM, DaSilva A, et al. (2004) fMRI measurement of CNS responses to naloxone infusion and subsequent mild noxious thermal stimuli in healthy volunteers. Journal of neurophysiology 91: 2723-2733.
10. Upadhyay J, Anderson J, Schwarz AJ, Coimbra A, Baumgartner R, et al. (2011) Imaging Drugs with and without Clinical Analgesic Efficacy. Neuropsychopharmacology.
11. Gear RW, Gordon NC, Miaskowski C, Paul SM, Heller PH, et al. (2003) Dose ratio is important in maximizing naloxone enhancement of nalbuphine analgesia in humans. Neurosci Lett 351: 5-8.
12. Zhang Y, Brady M, Smith S, (2001) Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20: 45-57.
13. Jenkinson M, Bannister P, Brady M, Smith S, (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17: 825-841.
14. Smith SM, (2002) Fast robust automated brain extraction. Hum Brain Mapp 17: 143-155.
15. Pendse G, Borsook D, Becerra L (2009) ADIS- A robust pursuit algorithm for probabilistic, constrained and non-square blind source separation with application to fMRI. ArXiv e-prints: ARXIV. pp. 44.
16. Pendse GV, Schwarz AJ, Baumgartner R, Coimbra A, Upadhyay J, et al. (2010) Robust, unbiased general linear model estimation of phMRI signal amplitude in the presence of variation in the temporal response profile. J Magn Reson Imaging 31: 1445-1457.
17. Woolrich MW, Behrens TEJ, Beckmann CF, Jenkinson M, Smith SM, (2004) Multilevel linear modelling for FMRI group analysis using Bayesian inference. Neuroimage 21: 1732-1747.
18. Smith SM, Miller KL, Salimi-Khorshidi G, Webster M, Beckmann CF, et al. (2011) Network modelling methods for FMRI. Neuroimage 54: 875-891.
19. Pendse G, Borsook D, Becerra L, (2009) Enhanced false discovery rate using Gaussian mixture models for thresholding fMRI statistical maps. Neuroimage 47: 231-261.
20. Besag J, (1986) On the statistical analysis of dirty pictures. J R Stat Soc Ser B Meth 48: 259-302.
21. Burstein R, Jakubowski M, Garcia-Nicas E, Kainz V, Bajwa Z, et al. (2010) Thalamic sensitization transforms localized pain into widespread allodynia. Ann Neurol 68: 81-91.
22. Wanigasekera V, Lee MCH, Rogers R, Hu P, Tracey I, (2011) Neural correlates of an injury-free model of central sensitization induced by opioid withdrawal in humans. J Neurosci 31: 2835-2842.
23. Oertel BG, Preibisch C, Martin T, Walter C, Gamer M, et al. (2011) Separating brain processing of pain from that of stimulus intensity. Hum Brain Mapp.
24. Moulton EA, Schmahmann JD, Becerra L, Borsook D, (2010) The cerebellum and pain: passive integrator or active participator? Brain Res Rev 65: 14-27.
25. Borsook D, Upadhyay J, Chudler EH, Becerra L, (2010) A key role of the basal ganglia in pain and analgesia-insights gained through human functional imaging. Mol Pain 6: 27.
26. Craig AD, (2010) The sentient self. Brain structure & function 214: 563-577.
27. Taylor KS, Seminowicz DA, Davis KD, (2009) Two systems of resting state connectivity between the insula and cingulate cortex. Human brain mapping 30: 2731-2745.
28. Garavan H, (2010) Insula and drug cravings. Brain structure & function 214: 593-601.
29. Baumgartner U, Buchholz HG, Bellosevich A, Magerl W, Siessmeier T, et al. (2006) High opiate receptor binding potential in the human lateral pain system. NeuroImage 30: 692-699.
30. Zelaya FO, Zois E, Muller-Pollard C, Lythgoe DJ, Lee S, et al. (2012) The response to rapid infusion of fentanyl in the human brain measured using pulsed arterial spin labelling. Magma 25: 163-175.
31. Berkowitz BA, (1976) The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone. Clin Pharmacokinet 1: 219-230.
32. Derbyshire SWG, Whalley MG, Stenger VA, Oakley DA, (2004) Cerebral activation during hypnotically induced and imagined pain. Neuroimage 23: 392-401.
33. Kong J, Gollub RL, Polich G, Kirsch I, Laviolette P, et al. (2008) A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effect. J Neurosci 28: 13354-13362.
34. Calejesan AA, Kim SJ, Zhuo M, (2000) Descending facilitatory modulation of a behavioral nociceptive response by stimulation in the adult rat anterior cingulate cortex. Eur J Pain 4: 83-96.
35. Senapati AK, Lagraize SC, Huntington PJ, Wilson HD, Fuchs PN, et al. (2005) Electrical stimulation of the anterior cingulate cortex reduces responses of rat dorsal horn neurons to mechanical stimuli. J Neurophysiol 94: 845-851.
36. An X, Bandler R, Ongür D, Price JL, (1998) Prefrontal cortical projections to longitudinal columns in the midbrain periaqueductal gray in macaque monkeys. J Comp Neurol 401: 455-479.
37. Floyd NS, Price JL, Ferry AT, Keay KA, Bandler R, (2000) Orbitomedial prefrontal cortical projections to distinct longitudinal columns of the periaqueductal gray in the rat. J Comp Neurol 422: 556-578.
38. Kong J, Tu P-c, Zyloney C, Su T-p, (2010) Intrinsic functional connectivity of the periaqueductal gray, a resting fMRI study. Behav Brain Res 211: 215-219.
39. Derbyshire SWG, Nichols TE, Firestone L, Townsend DW, Jones AKP, (2002) Gender differences in patterns of cerebral activation during equal experience of painful laser stimulation. J Pain 3: 401-411.
40. Upadhyay J, Anderson J, Schwarz AJ, Coimbra A, Baumgartner R, et al. (2011) Imaging drugs with and without clinical analgesic efficacy. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 36: 2659-2673.
41. Rabiner EA, Beaver J, Makwana A, Searle G, Long C, et al. (2011) Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans. Molecular psychiatry 16: 826-835, 785.
42. Becerra L, Breiter HC, Wise R, Gonzalez RG, Borsook D, (2001) Reward circuitry activation by noxious thermal stimuli. Neuron 32: 927-946.